• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重症患者开始肾脏替代治疗后的液体管理轨迹:STARRT-AKI试验的二次分析

Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial.

作者信息

Beaubien-Souligny William, Gamarian Ehsan, Côté Jean-Maxime, Neyra Javier A, Baroz Frederic, Adhikari Neill K J, Thorpe Kevin, Bagshaw Sean M, Wald Ron

机构信息

Division of Nephrology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada.

Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Canada.

出版信息

Crit Care. 2025 May 27;29(1):216. doi: 10.1186/s13054-025-05447-y.

DOI:10.1186/s13054-025-05447-y
PMID:40426163
Abstract

BACKGROUND

Fluid management is an essential component of renal replacement therapy (RRT) in critically ill patients. Both a positive cumulative fluid balance (CFB) and a high net ultrafiltration (NUF) rate have been reported to be associated with adverse outcomes in epidemiological studies, although the overall trajectory of fluid balance after RRT initiation is not well-described. We aimed to characterize trajectories of fluid management parameters during RRT and analyse the effect of CFB/NUF on outcomes as a trajectory rather than single or aggregated time points over the first week after initiation of RRT.

METHODS

This is a secondary analysis using fluid balance data focusing on individuals enrolled in the standard-strategy arm of the STARRT-AKI trial who initiated RRT. Cumulative fluid balance (CFB) following RRT initiation and daily net ultrafiltration (NUF) adjusted for body weight during the first 7 days after initiation of RRT were the main independent exposures. We modeled the trajectory of fluid parameters using spline functions and used latent trajectory analysis methods to identify predominant trajectories to compare patients' characteristics and outcomes. We employed logistic regression and multivariable joint longitudinal models to compare the odds and determine the time-dependent association between fluid parameters (CFB and NUF) and 90-day mortality across and within the trajectory classes identified.

RESULTS

We included 855 patients in the primary analysis. After excluding erroneous fluid balance data, we identified two distinct CFB/NUF trajectories. Class A (82.8%) was characterized by a slight increase in CFB and low/stable NUF during the week following RRT initiation while class B (17.2%) was characterized by an increasingly negative CFB with initially higher daily NUF during the first 4 days followed by a stabilization after day 4. In an adjusted analysis, individuals classified in class B were at lower risk for 90-day mortality (aOR: 0.48 CI 0.32; 0.70) p < 0.001) compared to class A. Time-dependent analysis revealed higher CFB was associated with mortality only in those with a class A trajectory (aHR 1.29, 95% CI 1.03-1.55, p = 0.03).

CONCLUSIONS

Distinct CFB/NUF trajectories convey prognostic information beyond single-day fluid balance or NUF values and should be considered when formulating or interpreting fluid management strategies.

摘要

背景

液体管理是危重症患者肾脏替代治疗(RRT)的重要组成部分。在流行病学研究中,累积液体平衡(CFB)为正和高净超滤(NUF)率均与不良结局相关,尽管RRT开始后液体平衡的总体轨迹尚未得到充分描述。我们旨在描述RRT期间液体管理参数的轨迹,并分析CFB/NUF作为一种轨迹而非RRT开始后第一周内的单个或汇总时间点对结局的影响。

方法

这是一项二次分析,使用的液体平衡数据聚焦于参与STARRT-AKI试验标准策略组且开始RRT的个体。RRT开始后的累积液体平衡(CFB)以及RRT开始后前7天根据体重调整的每日净超滤(NUF)是主要的独立暴露因素。我们使用样条函数对液体参数的轨迹进行建模,并使用潜在轨迹分析方法来识别主要轨迹以比较患者的特征和结局。我们采用逻辑回归和多变量联合纵向模型来比较比值,并确定在已识别的轨迹类别之间和之内液体参数(CFB和NUF)与90天死亡率之间的时间依赖性关联。

结果

我们在初步分析中纳入了855例患者。在排除错误的液体平衡数据后,我们识别出两种不同的CFB/NUF轨迹。A类(82.8%)的特征是RRT开始后一周内CFB略有增加且NUF低/稳定,而B类(17.2%)的特征是CFB越来越负,在开始的4天内每日NUF最初较高,随后在第4天后趋于稳定。在一项校正分析中,与A类相比,分类为B类的个体90天死亡率风险较低(校正比值比:0.48,置信区间0.32;0.70,p<0.001)。时间依赖性分析显示,仅在具有A类轨迹的患者中,较高的CFB与死亡率相关(校正风险比1.29,95%置信区间1.03-1.55,p=0.03)。

结论

不同的CFB/NUF轨迹所传达的预后信息超出了单日液体平衡或NUF值,在制定或解释液体管理策略时应予以考虑。

相似文献

1
Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial.危重症患者开始肾脏替代治疗后的液体管理轨迹:STARRT-AKI试验的二次分析
Crit Care. 2025 May 27;29(1):216. doi: 10.1186/s13054-025-05447-y.
2
Net ultrafiltration intensity and mortality in critically ill patients with fluid overload.液体超负荷的危重症患者的净超滤强度与死亡率。
Crit Care. 2018 Sep 24;22(1):223. doi: 10.1186/s13054-018-2163-1.
3
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study.连续肾脏替代治疗的危重症患者中,液体清除与更好的结局相关:一项队列研究。
Crit Care. 2020 Jun 1;24(1):279. doi: 10.1186/s13054-020-02986-4.
4
Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial.液体平衡和肾脏替代治疗启动策略:STARRT-AKI 试验的二次分析。
Crit Care. 2022 Nov 24;26(1):360. doi: 10.1186/s13054-022-04229-0.
5
Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial.网络超滤率与接受连续性静脉-静脉血液滤过治疗的急性肾损伤危重症成人死亡率的相关性:肾脏替代治疗随机评估正常 vs 增强水平(RENAL)试验的二次分析。
JAMA Netw Open. 2019 Jun 5;2(6):e195418. doi: 10.1001/jamanetworkopen.2019.5418.
6
Early net ultrafiltration thresholds and mortality in critically ill patients with septic acute kidney injury receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的脓毒症急性肾损伤重症患者的早期净超滤阈值与死亡率
Ren Fail. 2025 Dec;47(1):2511277. doi: 10.1080/0886022X.2025.2511277. Epub 2025 May 29.
7
Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis.区域实践差异与急性肾损伤中标准与加速肾脏替代治疗启动(STARRT-AKI)试验的结局:事后二次分析。
Crit Care Explor. 2024 Feb 19;6(2):e1053. doi: 10.1097/CCE.0000000000001053. eCollection 2024 Feb.
8
Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study.危重症患者接受肾脏替代治疗时的液体平衡、透析中低血压及预后:一项队列研究
Crit Care. 2014 Nov 18;18(6):624. doi: 10.1186/s13054-014-0624-8.
9
Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials.重症监护中的分层终点:急性肾损伤中肾脏替代治疗标准启动与加速启动以及危重症患者连续肾脏替代治疗强度的事后探索性分析。
J Crit Care. 2024 Aug;82:154767. doi: 10.1016/j.jcrc.2024.154767. Epub 2024 Mar 11.
10
The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.危重症患者液体评估的剂量反应多中心研究(DoReMIFA)
Crit Care. 2016 Jun 23;20(1):196. doi: 10.1186/s13054-016-1355-9.

本文引用的文献

1
Moderate IV Fluid Resuscitation Is Associated With Decreased Sepsis Mortality.中度静脉输液复苏与降低脓毒症死亡率相关。
Crit Care Med. 2024 Nov 1;52(11):e557-e567. doi: 10.1097/CCM.0000000000006394. Epub 2024 Aug 23.
2
Vascular leak in sepsis: physiological basis and potential therapeutic advances.脓毒症中的血管渗漏:生理基础和潜在的治疗进展。
Crit Care. 2024 Mar 23;28(1):97. doi: 10.1186/s13054-024-04875-6.
3
Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey.
急性肾损伤行肾脏替代治疗的危重症患者的液体管理:国际调查。
Clin J Am Soc Nephrol. 2023 Jun 1;18(6):705-715. doi: 10.2215/CJN.0000000000000157. Epub 2023 Mar 28.
4
Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial.液体平衡和肾脏替代治疗启动策略:STARRT-AKI 试验的二次分析。
Crit Care. 2022 Nov 24;26(1):360. doi: 10.1186/s13054-022-04229-0.
5
Assessment of prescribed vs. achieved fluid balance during continuous renal replacement therapy and mortality outcome.评估连续性肾脏替代治疗期间规定的与实现的液体平衡与死亡率结局。
PLoS One. 2022 Aug 25;17(8):e0272913. doi: 10.1371/journal.pone.0272913. eCollection 2022.
6
Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.接受持续肾脏替代治疗的急性肾损伤成年危重症患者的净超滤率与肾脏恢复之间的关联:一项观察性队列研究
Blood Purif. 2022;51(5):397-409. doi: 10.1159/000517281. Epub 2021 Jul 21.
7
Continuous Renal Replacement Therapy: The Interaction between Fluid Balance and Net Ultrafiltration.连续性肾脏替代治疗:液体平衡与净超滤之间的相互作用
Am J Respir Crit Care Med. 2021 May 1;203(9):1199-1201. doi: 10.1164/rccm.202011-4097LE.
8
Ultrafiltration in critically ill patients treated with kidney replacement therapy.危重症患者在肾脏替代治疗中的超滤。
Nat Rev Nephrol. 2021 Apr;17(4):262-276. doi: 10.1038/s41581-020-00358-3. Epub 2020 Nov 11.
9
Practitioner's Guide to Latent Class Analysis: Methodological Considerations and Common Pitfalls.潜类分析实用指南:方法学考虑因素及常见陷阱。
Crit Care Med. 2021 Jan 1;49(1):e63-e79. doi: 10.1097/CCM.0000000000004710.
10
Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.小时净超滤率对连续性肾脏替代治疗危重症患者死亡率影响的中介因素。
Crit Care Med. 2020 Oct;48(10):e934-e942. doi: 10.1097/CCM.0000000000004508.